The expression levels of CXCL16, CXCR6, S100A8/A9, FOXP3, CTLA4 and TIGIT were significantly upregulated in PJI samples of this validation cohort (Figure 5e–l). Here, CXCL16 is linked to juvenile polyposis syndrome.